Story
Merck KGaA Shares Rise After HSBC Upgrades Stock to 'Buy' on Valuation
Shares in Merck KGaA rose in early trading after HSBC upgraded the German conglomerate to 'Buy' from 'Hold,' citing an attractive relative valuation. The stock climbed 1.7% by 09:06 GMT, according to the source report.
Rationale for the Upgrade
In a note to clients, HSBC analysts led by Shubhangi Gupta highlighted that Merck KGaA's shares have not participated in the recent life sciences sector rally, despite posting one of the highest growth rates in its tools division during the first half of 2026. The bank named Merck KGaA one of its preferred picks in the sector, alongside Lonza, Danaher, and Agilent.
The analysts acknowledged potential risks for a slowdown in the second half of the year due to de-stocking. However, they believe this should be viewed in the context of tough comparisons and that acceleration in the company’s electronics segment should offset some of the softness in life sciences tools.
HSBC also commented on the company's merger and acquisition strategy, noting that Merck has historically been prudent. While their analysis of a potential Bio-Techne deal left them "unconvinced regarding the return accretion potential," they see long-term strategic value in bolstering capabilities in areas like cell therapy.
AdBroader Sector Outlook
The upgrade comes amid a broader debate over the durability of a three-month rally in Life Sciences Tools and Services stocks. According to HSBC, the recent positive performance has been driven by several factors:
- Improved demand signals from pharmaceutical and biotech clients.
- Resilient performance from contract drug manufacturers (CDMOs).
- Stabilizing equipment trends and stronger order growth.
Looking ahead, HSBC identified several medium-term tailwinds for the sector. These include patent cliffs driving innovation, expanding demand for biologics-related technologies, and geopolitical shifts favoring Western suppliers. The analysts also noted that a strong rebound in biotech venture capital funding in the first half of 2026 is expected to benefit demand with a typical lag of four to eight months.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.